Abbott Laboratories

Abbott Laboratories beat expectations with a quarterly profit thanks to strong medical device sales.

Sales of glucose monitoring products were particularly strong.

An increase in demand for medical interventions supported overall growth.

Annual earnings of 98 cents per share beat analysts' estimates by 3 cents.

Abbott Laboratories $ABT raised its full-year forecast to $4.55 to $4...
Read more

📈 Investment Jewels in Healthcare 📈

Hello BuliosiansI have three kings of the healthcare industry here today! 💰

Johnson & Johnson $JNJ
Withover 62 years of consistent dividends and a AAA credit rating, JNJ isan interesting choice. The company is focused on pharmaceuticals, medical devices and technology, emphasizing consistency and durability. With a historically low forward P...
Read more

Well, it's a good thing I bought that Abbot for $100. Results mark ideal despite lowered expectations for the rest of the year regarding sales from covid products.